BRIDGEWAY CAPITAL MANAGEMENT, LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 81 filers reported holding IMMUNE DESIGN CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$248,000
+350.9%
42,4000.0%0.00%
+200.0%
Q4 2018$55,000
-92.8%
42,400
-80.8%
0.00%
-85.7%
Q3 2018$763,000
+106.2%
221,192
+172.1%
0.01%
+75.0%
Q2 2018$370,000
-34.0%
81,292
-52.2%
0.00%
-33.3%
Q1 2018$561,000
+24.9%
170,000
+47.8%
0.01%
+20.0%
Q4 2017$449,000
-62.9%
115,000
-1.5%
0.01%
-64.3%
Q3 2017$1,209,000
+7.9%
116,800
+1.6%
0.01%0.0%
Q2 2017$1,121,000
+43.4%
115,0000.0%0.01%
+55.6%
Q1 2017$782,000
+23.5%
115,0000.0%0.01%
+12.5%
Q4 2016$633,000
-27.4%
115,0000.0%0.01%
-38.5%
Q3 2016$872,000115,0000.01%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2018
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders